These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 8955490)

  • 1. Cosmetic industry. Year in review: 1995/1996.
    Barker MO
    Am J Contact Dermat; 1996 Dec; 7(4):251-3. PubMed ID: 8955490
    [No Abstract]   [Full Text] [Related]  

  • 2. The cosmetic ingredient review self-regulatory safety program.
    Bergfeld WF; Elder RL; Schroeter AL
    Dermatol Clin; 1991 Jan; 9(1):105-22. PubMed ID: 2022088
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The cosmetic/drug dilemma: FDA regulation of alpha-hydroxy acids.
    Heymann LA
    Food Drug Law J; 1997; 52(4):357-75. PubMed ID: 10346670
    [No Abstract]   [Full Text] [Related]  

  • 4. Drugs are for beauty too.
    Nature; 2003 Aug; 424(6952):981. PubMed ID: 12944925
    [No Abstract]   [Full Text] [Related]  

  • 5. Online registration for cosmetic industry.
    FDA Consum; 2006; 40(1):4. PubMed ID: 16528819
    [No Abstract]   [Full Text] [Related]  

  • 6. Fifty years of cosmetic safety: a government and industry partnership.
    Donegan TJ
    Food Drug Law J; 1995; 50 Spec():151-62. PubMed ID: 10343040
    [No Abstract]   [Full Text] [Related]  

  • 7. The cosmetic ingredient review: a status report.
    Beyer KH
    Clin Ther; 1981; 4(1):2-6. PubMed ID: 7273066
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cosmetic safety: is there any?
    Simmons S
    Nursing; 2012 May; 42(5):54-5. PubMed ID: 22531078
    [No Abstract]   [Full Text] [Related]  

  • 9. The impact of regulation.
    Magazine AH
    Med Device Technol; 1997 Mar; 8(2):38-44, 46, 48. PubMed ID: 10166366
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Perception and process at the Food and Drug Administration: obligations and trade-offs in rules and guidances.
    Seiguer E; Smith JJ
    Food Drug Law J; 2005; 60(1):17-32. PubMed ID: 15940852
    [No Abstract]   [Full Text] [Related]  

  • 11. Regulation of cosmetics that are also drugs.
    Greff JA
    Food Drug Law J; 1996; 51(2):243-72. PubMed ID: 11820201
    [No Abstract]   [Full Text] [Related]  

  • 12. Implications of FDA's proposal to include foreign marketing experience in the over-the-counter drug review process.
    Pinco RG
    Food Drug Law J; 1998; 53(1):105-22. PubMed ID: 11795327
    [No Abstract]   [Full Text] [Related]  

  • 13. The history and contemporary challenges of the US Food and Drug Administration.
    Borchers AT; Hagie F; Keen CL; Gershwin ME
    Clin Ther; 2007 Jan; 29(1):1-16. PubMed ID: 17379043
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of the courts in drug decisions.
    Archambault GF
    Hosp Formul; 1977 Apr; 12(4):272. PubMed ID: 10236475
    [No Abstract]   [Full Text] [Related]  

  • 15. Not in my makeup: the need for enhanced premarket regulatory authority over cosmetics in light of increased usage of engineered nanoparticles.
    Johnson DR
    J Contemp Health Law Policy; 2009; 26(1):82-124. PubMed ID: 20112620
    [No Abstract]   [Full Text] [Related]  

  • 16. Mirror, mirror on the wall, what's in my personal care products: a short article about 300 million "guinea pigs".
    Sattler B; Archer L; Houlihan J
    Oreg Nurse; 2006 Sep; 71(3):10. PubMed ID: 16989178
    [No Abstract]   [Full Text] [Related]  

  • 17. US voters' love of Canada's Internet drugstores making politicians cautious.
    Whitwham B
    CMAJ; 2003 Apr; 168(8):1033. PubMed ID: 12695403
    [No Abstract]   [Full Text] [Related]  

  • 18. Annual Review of Cosmetic Ingredient Safety Assessments--2001/2002.
    Cosmetic Ingredient Review Expert Panel
    Int J Toxicol; 2003; 22 Suppl 1():1-35. PubMed ID: 12851163
    [No Abstract]   [Full Text] [Related]  

  • 19. Direct-to-OTC marketing of drugs: possible approaches.
    Mahinka SP; Bierman ME
    Food Drug Law J; 1995; 50(1):49-63. PubMed ID: 10342985
    [No Abstract]   [Full Text] [Related]  

  • 20. Kiss and make-up: a need for consolidation of FDA and cosmetic industry regulation programs.
    Mason DE
    Health Matrix Clevel; 2008; 18(1):181-207. PubMed ID: 19161130
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.